Avita Medical | 1811094D - Ebit



金融业
股票价格
AUD 4.55
资产
AUD 47.78M
现金及等价物
AUD 9.14M
销售成本
AUD 3.94M
流动资产
AUD 28.39M
流动负债
AUD 68.71M
债务
AUD 48.48M
EBIT
AUD -6.17M
EBITDA
AUD -5.56M
员工
AUD 87
EPS每股收益
AUD -0.25
股本和储备
AUD -27.84M
销售毛利
AUD 17.77M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 599.13M
净收入
AUD -7.66M
营业费用
AUD 28.56M
营业利润
AUD -6.86M
普通股股本
423.49M
税前利润
AUD -7.63M
销售收入
AUD 21.7M
销售和管理费用
AUD 19.54M
股票
AUD 5.29M
贸易债权人
AUD 6.42M
应收帐款人
AUD 9.87M


Ebit 更改 日
Accuray USD 11.38M 12.71M 2024-09
Celltrion KRW 20.08B 6.67B 2026-06
Clinuvel Pharmaceuticals AUD 13.51M 15.95M 2025-12
Cochlear AUD 261.1M 13.9M 2025-12
CSL USD 2.64B 116M 2025-12
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -61.48M 14.95M 2026-06
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Kangmei Pharma CNY -35.26M 22.54M 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 300K 2024-12
Mayne Pharma AUD -16.2M 13.2M 2024-06
Medical Developments International AUD -36K 12.96M 2025-12
Nanosonics AUD 9.12M 422K 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Organigram Holdings CAD 5.33M 15.12M 2026-06
Ovoca Bio EUR -173K 990K 2025-12
Pacific Edge NZD -16.94M 2.46M 2026-06
Pharma Mar EUR 7.65M 9.06M 2026-09
Polynovo AUD 2.06M 1.18M 2025-12
PYC Therapeutics AUD -22.59M 3.25M 2025-12
Qiagen NV USD 141.4M 44.52M 2026-06
Ramsay Health Care AUD 541.1M 20.7M 2025-12
ResMed USD 448.71M 51.1M 2026-06
Sartorius EUR 179.8M 15.8M 2026-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Telix Pharmaceuticals AUD 46.36M 38.32M 2026-06
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -389M 318.05M 2026-03
Zz Pientze Pharmaceu CNY 222.81M 140.02M 2026-09